CNSP

Cns Pharmaceuticals
$5.07
−$0.16 (−3.06%)Jul 27, 2026
0.2PoorMoatMint rating

MoatMint rates Cns Pharmaceuticals (CNSP) 0.2 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 1.3 out of 10.

Key metrics

The numbers that frame CNSP today
Market cap
$7.41M
P/E (TTM)
-0.4
EV / FCF
-0.3
ROIC
1,732%
Div yield
0%
Debt / equity
3.3
52wk Low
$1.90
52wk High
$10.59

CNSP stock rating

How CNSP scores on quality, value, growth, momentum and financial health
0.2out of 10
Low overallNeutral business, expensive priceTop 98% of ~5,000 US stocks
QualityPoor1.3/10
GrowthPoor0.1/10
MomentumFair3.0/10
ValuePoor0.1/10
Financial HealthPoor0.8/10

Growth

Revenue and earnings trend for CNSP
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about CNSP
Is Cns Pharmaceuticals a good buy?
No. Cns Pharmaceuticals has poor quality and weak momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case. We think Cns Pharmaceuticals is selling at a very high price.
What is the market capitalization of CNSP?
Cns Pharmaceuticals's market capitalization is $7.41M.
What is the P/E ratio for CNSP stock?
Cns Pharmaceuticals's current P/E ratio is -0.4.
What is the 52-week high for CNSP stock?
The 52-week high for Cns Pharmaceuticals is $10.59. The current close of $5.07 is 52.1% below that high.
What is the 52-week low for CNSP stock?
The 52-week low for Cns Pharmaceuticals is $1.90. The current close of $5.07 is 166.8% above that low.
Does CNSP stock pay dividends?
Cns Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for CNSP?
Cns Pharmaceuticals's Debt / Equity ratio is 3.29.